RNAIndel
RNAIndel identifies and classifies somatic insertions and deletions (indels) from tumor RNA-sequencing (RNA-Seq) data to distinguish somatic, germline, and artifact events in expressed tumor transcriptomes.
Key Features:
- Indel Classification: Classifies indels into somatic, germline, and artifact categories based on their origin and characteristics within tumor transcriptomes.
- Postprocessing Capability: Can serve as a postprocessor to classify indels identified by other variant callers.
- Genome Build Support: Supports both GRCh38 and GRCh37 genome builds.
- Artifact-aware Detection: Accounts for artifacts introduced during PCR-based library preparation when distinguishing true variants from artifacts.
- Tumor-only Operation: Detects expressed somatic indels from tumor RNA-Seq data in the absence of matched normal RNA-Seq.
Scientific Applications:
- Somatic Indel Prediction: Predicts somatic indels across various cancer types, including pediatric and adult cancers.
- Subclonal Driver Indel Recovery: Recovers subclonal driver indels with variant allele frequencies (VAF) in the 0.01 to 0.15 range.
- Performance Superiority: Achieves sensitivity between 88% and 100% while producing 14 times fewer false positives than best-practice RNA-Seq variant calling methods.
Methodology:
Employs a machine-learning framework that uses features derived from the sequence context surrounding indels and their biological effects to differentiate somatic events from artifacts and germline variations.
Topics
Details
- License:
- Apache-2.0
- Cost:
- Free of charge
- Programming Languages:
- Python
- Added:
- 1/9/2020
- Last Updated:
- 11/25/2024
Operations
Data Inputs & Outputs
Annotation
Inputs
Outputs
Publications
Hagiwara K, Ding L, Edmonson MN, Rice SV, Newman S, Easton J, Dai J, Meshinchi S, Ries RE, Rusch M, Zhang J. RNAIndel: discovering somatic coding indels from tumor RNA-Seq data. Bioinformatics. 2019;36(5):1382-1390. doi:10.1093/bioinformatics/btz753. PMID:31593214. PMCID:PMC7523641.
PMID: 31593214
PMCID: PMC7523641
Funding: - National Institute of General Medical Sciences: P50GM115279-03